Autologous T Cells Expressing Enhanced TCRs Specific for MAGEA3/A6/B18 or NYESO-1/LAGE in Patients With Ovarian Cancer

This study has been withdrawn prior to enrollment.

(Site decided to withdraw participation.)

Sponsor:

Collaborators:

Roswell Park Cancer Institute

Adaptimmune

Information provided by (Responsible Party):

University of Pennsylvania

ClinicalTrials.gov Identifier:

NCT01567891

First received: March 16, 2012

Last updated: January 31, 2013

Last verified: January 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Study Completion Date:	January 2013
Primary Completion Date:	January 2013 (Final data collection date for primary outcome measure)